1,169
Participants
Start Date
December 31, 2005
Primary Completion Date
July 31, 2009
Study Completion Date
July 31, 2009
Lamotrigine + Aripiprazole
"Tablets, Oral, once daily, Phase 1 (all subjects) - up to 24 weeks; Phase 2 - up to 52 weeks~Lamotrigine 100-200 mg/day~Aripiprazole 10-30 mg/day"
Lamotrigine + Placebo
"Tablets, Oral, once daily, Phase 2 - up to 52 weeks~Lamotrigine 100-200 mg/day~placebo 0 mg/day"
Richmond Behavioral Associates, Staten Island
Buffalo Psychiatric Center, Buffalo
Finger Lakes Clinical Research, Rochester
Dubois Regional Medical Center, DuBois
Lehigh Valley Hospital, Allentown
Lehigh Center For Clinical Research, Allentown
Freimer, Martin, East Stroudsburg
University Of Pennsylvania, Philadelphia
Belmont Center For Comprehensive Treatment, Philadelphia
Cns Research Institute, Philadelphia
Capital Clinical Research Associates, Rockville
Clinical Insights, Glen Burnie
Sheppard Pratt Health System, Baltimore
University Of Virginia Health System, Charlottesville
Windwood Centre, Virginia Beach
Health Research Center, Morgantown
Zarzar Psychiatric Associates, Pllc, Raleigh
Duke University Medical Center, Durham
Comprehensive Neuroscience, Inc, Atlanta
Act Clinical Research Institute, Llc, Daytona Beach
Cns Clinical Research Group, Coral Springs
Aurora-Cuervo Clinical Trials, Miami
Janus Center For Psychiatric Research, West Palm Beach
Health Sciences America, Llc, Boca Raton
Neuropsychiatric Research Center Of Southwest Florida, Fort Myers
Gulf Coast Medical Research, Port Charlotte
University Of Alabama At Birmingham, Birmingham
Psychiatric Consultants, Pc, Nashville
Harmony Research, Llc, Piney Flats
Ut Medical Group/Odyssey Research, Memphis
Precise Research Centers, Flowood
University Of Kentucky, Dept. Of Psychiatry, Lexington
Owensboro Behavioral Care, Owensboro
Saroj Brar Md, Inc, Cleveland
Neuro Behavioral Clinical Research, Inc., Canton
Community Research, Cincinnati
Valle Vista Health System, Greenwood
Clinco, Terre Haute
Psychopharmacology Research Corporation, Farmington Hills
Aurora Health Care, Milwaukee
Regions Hospital, Saint Paul
University Of Minnesota, Minneapolis
Horizon Medical Services, Bismarck
Clinical Trials Technology, Inc, Prairie Village
Clinical Research Institute, Wichita
University Of Oklahoma Health Sciences Center, Oklahoma City
Cutting Edge Research, Oklahoma City
Bayou City Research, Ltd., Houston
Alamo Superior Research, San Antonio
Southwest Biomedical Research Foundation, Tucson
Pacific Institute For Medical Research, Inc., Los Angeles
Los Angeles Biomedical Research Institute, Torrance
Southern Ca Clinical Research, Inc., Pasadena
Pacific Clinical Research Medical Group, Upland
Excell Research, Oceanside
College Hospital Costa Mesa, Costa Mesa
Pravin Kansagra, M.D., Anaheim
Stanford University, Stanford
Summit Research Network, Portland
Pacific Institute Of Medical Sciences, Bothell
Summit Research Network (Seattle) Llc, Seattle
University Of Medicine & Dentistry Of New Jersey, Cherry Hill
Local Institution, Cabo Rojo
Local Institution, Ponce
Local Institution, Rio Piedras
Local Institution, San Juan
Collaborators (1)
Otsuka America Pharmaceutical
INDUSTRY
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY